RocketTheme Joomla Templates

Emissary in the Press

Emissary in the Clinical Research Industry Press

Emissary Presents at Southwest Equity Capital Summit

AUSTIN, Texas -- Emissary Inc. today announced that it will participate in the 2002 Southwest Equity Capital Summit organized by the Capital Network October 2-3 in Richardson, Texas. Steven Mayo, founder and CEO of Emissary, will present the company's plans to streamline drug and medical device research studies with a new Web-based software initiative.
Read more...

Emissary Technology Key to Enrolling First Patient Within 7 Days of FDA Approval of a Dialysis Graft Trial

Emissary in the Clinical Research Press
Emissary Inc. has been selected by Novoste Corporation (Nasdaq:NOVT) to collaborate on monitoring and clinical trial management of Novoste's BRAVO (Beta Radiation for treatment of Arterial-Venous graft Outflow) clinical trial.
Read more...

Clinical Trial Outsourcing Emerging as a Key Trend in Drug Research And Development Markets

Emissary in the Clinical Research Press \| Page-1 TORONTO, Nov. 12 /PRNewswire/ -- Contract research organizations (CROs) are a growing trend among the pharmaceutical and biotechnology sectors as these companies look to reduce the costs of drug development. However, there are tradeoffs between the size of a CRO and the therapeutic and local expertise dedicated to individual projects.
Read more...

<< Start < Prev 1 2 Next > End >>

Page 2 of 2

Contact Emissary

business phone system

Recent Articles

FDA Form 1572 - Guidance on the FDA's Statement of Investigator Form

In July 2008, FDA released a draft guidance to answer frequent questions about Form...

Illuminating the Diagnosis of Intracranial Hematoma

Without urgent pressure-relieving surgery, the chance of survival drops quickly for head trauma patients...

FDA’s Bioresearch Monitoring (BIMO) Inspections

BIMO, the Bioresearch Monitoring Program, is a Food and Drug Administration (FDA) program of on-site...

Most Popular